Concepedia

Ivan Lolli

IL

Statistics

Publications

22

Citations

991

H-Index

15

Active since

2005

Affiliations

Gastroenterology Hospital "Saverio de Bellis"(Current)

University of Bari Aldo Moro

Istituto Oncologico Veneto

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

Ivan Lolli is an author at Gastroenterology Hospital "Saverio de Bellis" specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2005–2024

22

Publications

22

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 367 citations

, , +10

A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib

Alessandra Santangelo, Marzia Rossato, Giuseppe Lombardi et al. · Neuro-Oncology · 2020 · 76 citations · Full text

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)

Riccardo Soffietti, Elisa Trevisan, Luca Bertero et al. · Journal of Neuro-Oncology · 2013 · 72 citations · Full text

A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma

Maria Grazia Fabrini, Giovanni Silvano, Ivan Lolli et al. · Journal of Neuro-Oncology · 2008 · 60 citations

, , +8

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials

Stefano Severi, Alberto Bongiovanni, M Ferrara et al. · ESMO Open · 2021 · 56 citations · Full text

1–5 of 22